PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
1-Year Return
55.52%
This Quarter Return
+10.79%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$14.6B
AUM Growth
+$951M
(+7%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
29.69%
Holding
330
New
34
Increased
99
Reduced
95
Closed
48
Top Buys
| 1 |
McKesson
MCK
|
$137M |
| 2 |
Synopsys
SNPS
|
$134M |
| 3 |
Rambus
RMBS
|
$84M |
| 4 |
NVIDIA
NVDA
|
$84M |
| 5 |
Amazon
AMZN
|
$82.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
$110M |
| 2 |
Teradyne
TER
|
$90.7M |
| 3 |
Apple
AAPL
|
$89.1M |
| 4 |
Visa
V
|
$74.5M |
| 5 |
United Therapeutics
UTHR
|
$72.6M |
Sector Composition
| 1 | Technology | 40.96% |
| 2 | Healthcare | 24.28% |
| 3 | Financials | 16.46% |
| 4 | Communication Services | 8.44% |
| 5 | Consumer Discretionary | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
BioMarin Pharmaceuticals
BMRN
$10.9B
| $36.8M | 0.19% |
425,000
| – | – |
|
102
Aflac
AFL
$58.1B
| $36.3M | 0.18% |
520,000
| – | – |
|
103
Enphase Energy
ENPH
$4.78B
| $36.1M | 0.18% |
215,656
+19,472
| +10% | +$3.26M |
|
104
LivaNova
LIVN
$3.18B
| $35.8M | 0.18% |
696,726
+40,310
| +6% | +$2.07M |
|
105
Insmed
INSM
$30.1B
| $35.7M | 0.18% |
1,691,349
| – | – |
|
106
Becton Dickinson
BDX
$54.8B
| $35.6M | 0.18% |
+134,996
| New | +$35.6M |
|
107
RLI Corp
RLI
$6.22B
| $35.5M | 0.18% |
520,000
| – | – |
|
108
Neurocrine Biosciences
NBIX
$13.9B
| $35.4M | 0.18% |
+375,000
| New | +$35.4M |
|
109
Addus HomeCare
ADUS
$2.06B
| $35.2M | 0.18% |
379,913
| – | – |
|
|
KRTX
110
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $32.8M | 0.17% |
+151,450
| New | +$32.8M |
|
111
ProAssurance
PRA
$1.22B
| $32.6M | 0.16% |
2,162,500
| – | – |
|
|
BPMC
112
DELISTED
Blueprint Medicines
BPMC
| $31.6M | 0.16% |
+500,000
| New | +$31.6M |
|
113
US Foods
USFD
$17.6B
| $31.5M | 0.16% |
716,350
-67,211
| -9% | -$2.96M |
|
114
Dynatrace
DT
$15B
| $31.2M | 0.16% |
605,555
-69,848
| -10% | -$3.6M |
|
115
Arcutis Biotherapeutics
ARQT
$1.94B
| $29.8M | 0.15% |
3,127,777
-7,736
| -0.2% | -$73.7K |
|
116
Denali Therapeutics
DNLI
$2.16B
| $29.7M | 0.15% |
1,007,086
+502,086
| +99% | +$14.8M |
|
117
Pliant Therapeutics
PLRX
$100M
| $29.7M | 0.15% |
1,640,000
-143,164
| -8% | -$2.59M |
|
|
CERE
118
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $29M | 0.15% |
910,762
+142,486
| +19% | +$4.53M |
|
119
Amdocs
DOX
$9.31B
| $26.9M | 0.14% |
272,271
-1,539
| -0.6% | -$152K |
|
120
Veeva Systems
VEEV
$44.3B
| $25.5M | 0.13% |
128,876
+46,957
| +57% | +$9.28M |
|
121
Alcon
ALC
$39B
| $25.5M | 0.13% |
310,082
-24,505
| -7% | -$2.01M |
|
122
Qiagen
QGEN
$10.2B
| $25.4M | 0.13% |
531,202
+116,052
| +28% | +$5.54M |
|
|
ITCI
123
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $25.3M | 0.13% |
400,000
| – | – |
|
124
Globant
GLOB
$2.75B
| $24.9M | 0.13% |
138,290
+5,815
| +4% | +$1.05M |
|
|
DCPH
125
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $24.6M | 0.12% |
1,750,000
| – | – |
|